analyticalMethodDevelopmentReport Collection

View documents in this collection

Documents

Showing up to 10 documents:

Document 1 - ID: 657848744d4c4c4ae97b57a5 
{"_id": {"$oid": "657848744d4c4c4ae97b57a5"}, "objectTypeId": {"$oid": "652411817ea5304f02443520"}, "version": 1, "collection": "analyticalMethodDevelopmentReport", "displayName": "Vancomycin For Injection [750mg/Vial, 1.25mg/vial, 1.5g/vial]", "externalId": "TK/ASD/AMD/2023/VAN/FP/RC/002/R0", "objectType": {"_id": {"$oid": "652411817ea5304f02443520"}, "externalId": "analyticalMethodDevelopmentReport", "displayName": "Analytical method development report", "version": 1}, "properties": [{"_id": {"$oid": "652411817ea5304f02443521"}, "externalId": "displayName", "displayName": "Report Name", "value": "Vancomycin For Injection [750mg/Vial, 1.25mg/vial, 1.5g/vial]", "choices": []}, {"_id": {"$oid": "652411817ea5304f02443522"}, "externalId": "externalId", "displayName": "Report Number", "value": "TK/ASD/AMD/2023/VAN/FP/RC/002/R0", "choices": []}, {"_id": {"$oid": "652411d67ea5304f02443529"}, "externalId": "typeOfStudy", "displayName": "Type of Study", "value": "NDSRI", "choices": []}, {"_id": {"$oid": "652413937ea5304f0244352a"}, "externalId": "reportDate", "displayName": "Report Date", "value": "1702319400", "choices": []}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec1"}, "externalId": "createdAt", "displayName": "Created At", "value": "1702381684"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec2"}, "externalId": "updatedAt", "displayName": "Updated At", "value": "1702381684"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec3"}, "externalId": "createdBy", "displayName": "Created By", "value": "382786184278302720"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec4"}, "externalId": "updatedBy", "displayName": "Updated By", "value": "382786184278302720"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec5"}, "externalId": "usageStatus", "displayName": "Usage Status", "value": "1"}], "relations": [{"_id": {"$oid": "652411c37ea5304f02443528"}, "externalId": "manufacturingProducts", "displayName": "Manufacturing Product", "targets": [{"_id": {"$oid": "6572a90b4d4c4c4ae97b3db4"}, "type": "OBJECTS", "collection": "manufacturingProducts", "externalId": "Vancomycin HCl injection", "displayName": "Vancomycin HCl injection"}], "objectTypeId": "6532d1fce5f40873f4aaebf6", "flags": 0}], "modifiedAt": 1702381684, "createdAt": 1702381684, "createdBy": {"_id": "382786184278302720", "employeeId": "3010", "firstName": "Prashantha", "lastName": "K"}, "modifiedBy": {"_id": "382786184278302720", "employeeId": "3010", "firstName": "Prashantha", "lastName": "K"}, "usageStatus": 1, "facilityId": "1693389002", "shortCode": "w3wyZoeR56", "searchable": {"652411817ea5304f02443521": "Vancomycin For Injection [750mg/Vial, 1.25mg/vial, 1.5g/vial]", "652411817ea5304f02443522": "TK/ASD/AMD/2023/VAN/FP/RC/002/R0", "652411c37ea5304f02443528": "6572a90b4d4c4c4ae97b3db4", "655ef3bb3484eb5056a36ec4": 382786184278302720, "655ef3bb3484eb5056a36ec5": 1, "652413937ea5304f0244352a": 1702319400, "652411d67ea5304f02443529": "NDSRI", "655ef3bb3484eb5056a36ec1": 1702381684, "655ef3bb3484eb5056a36ec2": 1702381684, "655ef3bb3484eb5056a36ec3": 382786184278302720}, "_class": "com.leucine.streem.collections.EntityObject"}
Document 2 - ID: 65a0db5d8e725f7ba1f40ac2 
{"_id": {"$oid": "65a0db5d8e725f7ba1f40ac2"}, "objectTypeId": {"$oid": "652411817ea5304f02443520"}, "version": 1, "collection": "analyticalMethodDevelopmentReport", "displayName": "Acetaminophen Orally Disintegrating tablets [80mg & 160mg]", "externalId": "TK/ASD/AMD/2024/ACE/FP/AS/001/R0", "objectType": {"_id": {"$oid": "652411817ea5304f02443520"}, "externalId": "analyticalMethodDevelopmentReport", "displayName": "Analytical method development report", "version": 1}, "properties": [{"_id": {"$oid": "652411817ea5304f02443521"}, "externalId": "displayName", "displayName": "Report Name", "value": "Acetaminophen Orally Disintegrating tablets [80mg & 160mg]", "choices": []}, {"_id": {"$oid": "652411817ea5304f02443522"}, "externalId": "externalId", "displayName": "Report Number", "value": "TK/ASD/AMD/2024/ACE/FP/AS/001/R0", "choices": []}, {"_id": {"$oid": "652411d67ea5304f02443529"}, "externalId": "typeOfStudy", "displayName": "Type of Study", "value": "Assay", "choices": []}, {"_id": {"$oid": "652413937ea5304f0244352a"}, "externalId": "reportDate", "displayName": "Report Date", "value": "1704911400", "choices": []}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec1"}, "externalId": "createdAt", "displayName": "Created At", "value": "1705040733"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec2"}, "externalId": "updatedAt", "displayName": "Updated At", "value": "1707711620"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec3"}, "externalId": "createdBy", "displayName": "Created By", "value": "382786184278302720"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec4"}, "externalId": "updatedBy", "displayName": "Updated By", "value": "382786184278302720"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec5"}, "externalId": "usageStatus", "displayName": "Usage Status", "value": "7"}], "relations": [{"_id": {"$oid": "652411c37ea5304f02443528"}, "externalId": "manufacturingProducts", "displayName": "Manufacturing Product", "targets": [{"_id": {"$oid": "6577e8494d4c4c4ae97b534b"}, "type": "OBJECTS", "collection": "manufacturingProducts", "externalId": "Paracetamol ODT", "displayName": "Paracetamol ODT"}], "objectTypeId": "6532d1fce5f40873f4aaebf6", "flags": 0}], "modifiedAt": 1705040733, "createdAt": 1705040733, "createdBy": {"_id": "382786184278302720", "employeeId": "3010", "firstName": "Prashantha", "lastName": "K"}, "modifiedBy": {"_id": "382786184278302720", "employeeId": "3010", "firstName": "Prashantha", "lastName": "K"}, "usageStatus": 7, "facilityId": "1693389002", "shortCode": "wSBxligkow", "searchable": {"652411817ea5304f02443521": "Acetaminophen Orally Disintegrating tablets [80mg & 160mg]", "652411817ea5304f02443522": "TK/ASD/AMD/2024/ACE/FP/AS/001/R0", "652411c37ea5304f02443528": "6577e8494d4c4c4ae97b534b", "655ef3bb3484eb5056a36ec4": 382786184278302720, "655ef3bb3484eb5056a36ec5": 1, "652413937ea5304f0244352a": 1704911400, "652411d67ea5304f02443529": "Assay", "655ef3bb3484eb5056a36ec1": 1705040733, "655ef3bb3484eb5056a36ec2": 1705040733, "655ef3bb3484eb5056a36ec3": 382786184278302720}, "_class": "com.leucine.streem.collections.EntityObject"}
Document 3 - ID: 65a665d38e725f7ba1f42a6f 
{"_id": {"$oid": "65a665d38e725f7ba1f42a6f"}, "objectTypeId": {"$oid": "652411817ea5304f02443520"}, "version": 1, "collection": "analyticalMethodDevelopmentReport", "displayName": "Acetaminophen Orally Disintegrating tablets [80mg & 160mg]", "externalId": "TK/ASD/AMD/2024/ACE/FP/DI/001/R0", "objectType": {"_id": {"$oid": "652411817ea5304f02443520"}, "externalId": "analyticalMethodDevelopmentReport", "displayName": "Analytical method development report", "version": 1}, "properties": [{"_id": {"$oid": "652411817ea5304f02443521"}, "externalId": "displayName", "displayName": "Report Name", "value": "Acetaminophen Orally Disintegrating tablets [80mg & 160mg]", "choices": []}, {"_id": {"$oid": "652411817ea5304f02443522"}, "externalId": "externalId", "displayName": "Report Number", "value": "TK/ASD/AMD/2024/ACE/FP/DI/001/R0", "choices": []}, {"_id": {"$oid": "652411d67ea5304f02443529"}, "externalId": "typeOfStudy", "displayName": "Type of Study", "value": "DISSOLUTION", "choices": []}, {"_id": {"$oid": "652413937ea5304f0244352a"}, "externalId": "reportDate", "displayName": "Report Date", "value": "1705343400", "choices": []}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec1"}, "externalId": "createdAt", "displayName": "Created At", "value": "1705403859"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec2"}, "externalId": "updatedAt", "displayName": "Updated At", "value": "1705403859"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec3"}, "externalId": "createdBy", "displayName": "Created By", "value": "382786184278302720"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec4"}, "externalId": "updatedBy", "displayName": "Updated By", "value": "382786184278302720"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec5"}, "externalId": "usageStatus", "displayName": "Usage Status", "value": "1"}], "relations": [{"_id": {"$oid": "652411c37ea5304f02443528"}, "externalId": "manufacturingProducts", "displayName": "Manufacturing Product", "targets": [{"_id": {"$oid": "6577e8494d4c4c4ae97b534b"}, "type": "OBJECTS", "collection": "manufacturingProducts", "externalId": "Paracetamol ODT", "displayName": "Paracetamol ODT"}], "objectTypeId": "6532d1fce5f40873f4aaebf6", "flags": 0}], "modifiedAt": 1705403859, "createdAt": 1705403859, "createdBy": {"_id": "382786184278302720", "employeeId": "3010", "firstName": "Prashantha", "lastName": "K"}, "modifiedBy": {"_id": "382786184278302720", "employeeId": "3010", "firstName": "Prashantha", "lastName": "K"}, "usageStatus": 1, "facilityId": "1693389002", "shortCode": "wZA1DA94iY", "searchable": {"652411817ea5304f02443521": "Acetaminophen Orally Disintegrating tablets [80mg & 160mg]", "652411817ea5304f02443522": "TK/ASD/AMD/2024/ACE/FP/DI/001/R0", "652411c37ea5304f02443528": "6577e8494d4c4c4ae97b534b", "655ef3bb3484eb5056a36ec4": 382786184278302720, "655ef3bb3484eb5056a36ec5": 1, "652413937ea5304f0244352a": 1705343400, "652411d67ea5304f02443529": "DISSOLUTION", "655ef3bb3484eb5056a36ec1": 1705403859, "655ef3bb3484eb5056a36ec2": 1705403859, "655ef3bb3484eb5056a36ec3": 382786184278302720}, "_class": "com.leucine.streem.collections.EntityObject"}
Document 4 - ID: 65adefa360e5686f91fb9643 
{"_id": {"$oid": "65adefa360e5686f91fb9643"}, "objectTypeId": {"$oid": "652411817ea5304f02443520"}, "version": 1, "collection": "analyticalMethodDevelopmentReport", "displayName": "Acetaminophen Orally Disintegrating tablets [80mg & 160mg]", "externalId": "TK/ASD/AMD/2024/ACE/FP/RC/001/R0  ", "objectType": {"_id": {"$oid": "652411817ea5304f02443520"}, "externalId": "analyticalMethodDevelopmentReport", "displayName": "Analytical method development report", "version": 1}, "properties": [{"_id": {"$oid": "652411817ea5304f02443521"}, "externalId": "displayName", "displayName": "Report Name", "value": "Acetaminophen Orally Disintegrating tablets [80mg & 160mg]", "choices": []}, {"_id": {"$oid": "652411817ea5304f02443522"}, "externalId": "externalId", "displayName": "Report Number", "value": "TK/ASD/AMD/2024/ACE/FP/RC/001/R0  ", "choices": []}, {"_id": {"$oid": "652411d67ea5304f02443529"}, "externalId": "typeOfStudy", "displayName": "Type of Study", "value": "Related substance", "choices": []}, {"_id": {"$oid": "652413937ea5304f0244352a"}, "externalId": "reportDate", "displayName": "Report Date", "value": "1705689000", "choices": []}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec1"}, "externalId": "createdAt", "displayName": "Created At", "value": "1705897891"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec2"}, "externalId": "updatedAt", "displayName": "Updated At", "value": "1707910950"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec3"}, "externalId": "createdBy", "displayName": "Created By", "value": "382786184278302720"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec4"}, "externalId": "updatedBy", "displayName": "Updated By", "value": "382786184278302720"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec5"}, "externalId": "usageStatus", "displayName": "Usage Status", "value": "7"}], "relations": [{"_id": {"$oid": "652411c37ea5304f02443528"}, "externalId": "manufacturingProducts", "displayName": "Manufacturing Product", "targets": [{"_id": {"$oid": "6577e8494d4c4c4ae97b534b"}, "type": "OBJECTS", "collection": "manufacturingProducts", "externalId": "Paracetamol ODT", "displayName": "Paracetamol ODT"}], "objectTypeId": "6532d1fce5f40873f4aaebf6", "flags": 0}], "modifiedAt": 1705897891, "createdAt": 1705897891, "createdBy": {"_id": "382786184278302720", "employeeId": "3010", "firstName": "Prashantha", "lastName": "K"}, "modifiedBy": {"_id": "382786184278302720", "employeeId": "3010", "firstName": "Prashantha", "lastName": "K"}, "usageStatus": 7, "facilityId": "1693389002", "shortCode": "x94qx2xOfu", "searchable": {"652411817ea5304f02443521": "Acetaminophen Orally Disintegrating tablets [80mg & 160mg]", "652411817ea5304f02443522": "TK/ASD/AMD/2024/ACE/FP/RC/001/R0  ", "652411c37ea5304f02443528": "6577e8494d4c4c4ae97b534b", "655ef3bb3484eb5056a36ec4": 382786184278302720, "655ef3bb3484eb5056a36ec5": 1, "652413937ea5304f0244352a": 1705689000, "652411d67ea5304f02443529": "Related substance", "655ef3bb3484eb5056a36ec1": 1705897891, "655ef3bb3484eb5056a36ec2": 1705897891, "655ef3bb3484eb5056a36ec3": 382786184278302720}, "_class": "com.leucine.streem.collections.EntityObject"}
Document 5 - ID: 65c5f89460e5686f91fc2cc5 
{"_id": {"$oid": "65c5f89460e5686f91fc2cc5"}, "objectTypeId": {"$oid": "652411817ea5304f02443520"}, "version": 1, "collection": "analyticalMethodDevelopmentReport", "displayName": "Container Closer Integrity Test for Succinylcholine Chloride Injection USP 100mg/5mL (20mg/mL)", "externalId": "TK/ASD/AMD/2024/SUC/FP/CC/001/R0", "objectType": {"_id": {"$oid": "652411817ea5304f02443520"}, "externalId": "analyticalMethodDevelopmentReport", "displayName": "Analytical method development report", "version": 1}, "properties": [{"_id": {"$oid": "652411817ea5304f02443521"}, "externalId": "displayName", "displayName": "Report Name", "value": "Container Closer Integrity Test for Succinylcholine Chloride Injection USP 100mg/5mL (20mg/mL)", "choices": []}, {"_id": {"$oid": "652411817ea5304f02443522"}, "externalId": "externalId", "displayName": "Report Number", "value": "TK/ASD/AMD/2024/SUC/FP/CC/001/R0", "choices": []}, {"_id": {"$oid": "652411d67ea5304f02443529"}, "externalId": "typeOfStudy", "displayName": "Type of Study", "value": "Container Closer Integrity Test", "choices": []}, {"_id": {"$oid": "652413937ea5304f0244352a"}, "externalId": "reportDate", "displayName": "Report Date", "value": "1707417000", "choices": []}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec1"}, "externalId": "createdAt", "displayName": "Created At", "value": "1707473044"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec2"}, "externalId": "updatedAt", "displayName": "Updated At", "value": "1707728915"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec3"}, "externalId": "createdBy", "displayName": "Created By", "value": "400503640670298112"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec4"}, "externalId": "updatedBy", "displayName": "Updated By", "value": "400503640670298112"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec5"}, "externalId": "usageStatus", "displayName": "Usage Status", "value": "7"}], "relations": [{"_id": {"$oid": "652411c37ea5304f02443528"}, "externalId": "manufacturingProducts", "displayName": "Manufacturing Product", "targets": [{"_id": {"$oid": "65a630fd8e725f7ba1f42848"}, "type": "OBJECTS", "collection": "manufacturingProducts", "externalId": " 1700000632 ", "displayName": "Succinylcholine Chloride Injection"}], "objectTypeId": "6532d1fce5f40873f4aaebf6", "flags": 0}], "modifiedAt": 1707473044, "createdAt": 1707473044, "createdBy": {"_id": "400503640670298112", "employeeId": "3011", "firstName": "Subrahmanya", "lastName": "B"}, "modifiedBy": {"_id": "400503640670298112", "employeeId": "3011", "firstName": "Subrahmanya", "lastName": "B"}, "usageStatus": 7, "facilityId": "1693389002", "shortCode": "xDksEJ6tc4", "searchable": {"652411817ea5304f02443521": "Container Closer Integrity Test for Succinylcholine Chloride Injection USP 100mg/5mL (20mg/mL)", "652411817ea5304f02443522": "TK/ASD/AMD/2024/SUC/FP/CC/001/R0", "652411c37ea5304f02443528": "65a630fd8e725f7ba1f42848", "655ef3bb3484eb5056a36ec4": 400503640670298112, "655ef3bb3484eb5056a36ec5": 1, "652413937ea5304f0244352a": 1707417000, "652411d67ea5304f02443529": "Container Closer Integrity Test", "655ef3bb3484eb5056a36ec1": 1707473044, "655ef3bb3484eb5056a36ec2": 1707473044, "655ef3bb3484eb5056a36ec3": 400503640670298112}, "_class": "com.leucine.streem.collections.EntityObject"}
Document 6 - ID: 65c99c8460e5686f91fc3e3e 
{"_id": {"$oid": "65c99c8460e5686f91fc3e3e"}, "objectTypeId": {"$oid": "652411817ea5304f02443520"}, "version": 1, "collection": "analyticalMethodDevelopmentReport", "displayName": "Acetaminophen Orally Disintegrating tablets [80mg & 160mg]", "externalId": "TK/ASD/AMD/2024/ACE/FP/AS/001/R1", "objectType": {"_id": {"$oid": "652411817ea5304f02443520"}, "externalId": "analyticalMethodDevelopmentReport", "displayName": "Analytical method development report", "version": 1}, "properties": [{"_id": {"$oid": "652411817ea5304f02443521"}, "externalId": "displayName", "displayName": "Report Name", "value": "Acetaminophen Orally Disintegrating tablets [80mg & 160mg]", "choices": []}, {"_id": {"$oid": "652411817ea5304f02443522"}, "externalId": "externalId", "displayName": "Report Number", "value": "TK/ASD/AMD/2024/ACE/FP/AS/001/R1", "choices": []}, {"_id": {"$oid": "652411d67ea5304f02443529"}, "externalId": "typeOfStudy", "displayName": "Type of Study", "value": "Assay", "choices": []}, {"_id": {"$oid": "652413937ea5304f0244352a"}, "externalId": "reportDate", "displayName": "Report Date", "value": "1707676200", "choices": []}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec1"}, "externalId": "createdAt", "displayName": "Created At", "value": "1707711620"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec2"}, "externalId": "updatedAt", "displayName": "Updated At", "value": "1707711620"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec3"}, "externalId": "createdBy", "displayName": "Created By", "value": "382786184278302720"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec4"}, "externalId": "updatedBy", "displayName": "Updated By", "value": "382786184278302720"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec5"}, "externalId": "usageStatus", "displayName": "Usage Status", "value": "1"}], "relations": [{"_id": {"$oid": "652411c37ea5304f02443528"}, "externalId": "manufacturingProducts", "displayName": "Manufacturing Product", "targets": [{"_id": {"$oid": "6577e8494d4c4c4ae97b534b"}, "type": "OBJECTS", "collection": "manufacturingProducts", "externalId": "Paracetamol ODT", "displayName": "Paracetamol ODT"}], "objectTypeId": "6532d1fce5f40873f4aaebf6", "flags": 0}], "modifiedAt": 1707711620, "createdAt": 1707711620, "createdBy": {"_id": "382786184278302720", "employeeId": "3010", "firstName": "Prashantha", "lastName": "K"}, "modifiedBy": {"_id": "382786184278302720", "employeeId": "3010", "firstName": "Prashantha", "lastName": "K"}, "usageStatus": 1, "facilityId": "1693389002", "shortCode": "xHUBObE3Ly", "searchable": {"652411817ea5304f02443521": "Acetaminophen Orally Disintegrating tablets [80mg & 160mg]", "652411817ea5304f02443522": "TK/ASD/AMD/2024/ACE/FP/AS/001/R1", "652411c37ea5304f02443528": "6577e8494d4c4c4ae97b534b", "655ef3bb3484eb5056a36ec4": 382786184278302720, "655ef3bb3484eb5056a36ec5": 1, "652413937ea5304f0244352a": 1707676200, "652411d67ea5304f02443529": "Assay", "655ef3bb3484eb5056a36ec1": 1707711620, "655ef3bb3484eb5056a36ec2": 1707711620, "655ef3bb3484eb5056a36ec3": 382786184278302720}, "_class": "com.leucine.streem.collections.EntityObject"}
Document 7 - ID: 65c9e01360e5686f91fc4284 
{"_id": {"$oid": "65c9e01360e5686f91fc4284"}, "objectTypeId": {"$oid": "652411817ea5304f02443520"}, "version": 1, "collection": "analyticalMethodDevelopmentReport", "displayName": "Container Closure Integrity Test by UV for Succinylcholine Chloride Injection, USP 100mg/5mL (20mg/mL)", "externalId": "TK/ASD/AMD/2024/SUC/FP/CC/001/R1", "objectType": {"_id": {"$oid": "652411817ea5304f02443520"}, "externalId": "analyticalMethodDevelopmentReport", "displayName": "Analytical method development report", "version": 1}, "properties": [{"_id": {"$oid": "652411817ea5304f02443521"}, "externalId": "displayName", "displayName": "Report Name", "value": "Container Closure Integrity Test by UV for Succinylcholine Chloride Injection, USP 100mg/5mL (20mg/mL)", "choices": []}, {"_id": {"$oid": "652411817ea5304f02443522"}, "externalId": "externalId", "displayName": "Report Number", "value": "TK/ASD/AMD/2024/SUC/FP/CC/001/R1", "choices": []}, {"_id": {"$oid": "652411d67ea5304f02443529"}, "externalId": "typeOfStudy", "displayName": "Type of Study", "value": "Container Closure Integrity Test by UV", "choices": []}, {"_id": {"$oid": "652413937ea5304f0244352a"}, "externalId": "reportDate", "displayName": "Report Date", "value": "1707676200", "choices": []}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec1"}, "externalId": "createdAt", "displayName": "Created At", "value": "1707728915"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec2"}, "externalId": "updatedAt", "displayName": "Updated At", "value": "1707728915"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec3"}, "externalId": "createdBy", "displayName": "Created By", "value": "400503640670298112"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec4"}, "externalId": "updatedBy", "displayName": "Updated By", "value": "400503640670298112"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec5"}, "externalId": "usageStatus", "displayName": "Usage Status", "value": "1"}], "relations": [{"_id": {"$oid": "652411c37ea5304f02443528"}, "externalId": "manufacturingProducts", "displayName": "Manufacturing Product", "targets": [{"_id": {"$oid": "65a630fd8e725f7ba1f42848"}, "type": "OBJECTS", "collection": "manufacturingProducts", "externalId": " 1700000632 ", "displayName": "Succinylcholine Chloride Injection"}], "objectTypeId": "6532d1fce5f40873f4aaebf6", "flags": 0}], "modifiedAt": 1707728915, "createdAt": 1707728915, "createdBy": {"_id": "400503640670298112", "employeeId": "3011", "firstName": "Subrahmanya", "lastName": "B"}, "modifiedBy": {"_id": "400503640670298112", "employeeId": "3011", "firstName": "Subrahmanya", "lastName": "B"}, "usageStatus": 1, "facilityId": "1693389002", "shortCode": "xIfcXilH32", "searchable": {"652411817ea5304f02443521": "Container Closure Integrity Test by UV for Succinylcholine Chloride Injection, USP 100mg/5mL (20mg/mL)", "652411817ea5304f02443522": "TK/ASD/AMD/2024/SUC/FP/CC/001/R1", "652411c37ea5304f02443528": "65a630fd8e725f7ba1f42848", "655ef3bb3484eb5056a36ec4": 400503640670298112, "655ef3bb3484eb5056a36ec5": 1, "652413937ea5304f0244352a": 1707676200, "652411d67ea5304f02443529": "Container Closure Integrity Test by UV", "655ef3bb3484eb5056a36ec1": 1707728915, "655ef3bb3484eb5056a36ec2": 1707728915, "655ef3bb3484eb5056a36ec3": 400503640670298112}, "_class": "com.leucine.streem.collections.EntityObject"}
Document 8 - ID: 65cca72660e5686f91fc5602 
{"_id": {"$oid": "65cca72660e5686f91fc5602"}, "objectTypeId": {"$oid": "652411817ea5304f02443520"}, "version": 1, "collection": "analyticalMethodDevelopmentReport", "displayName": "Acetaminophen Orally Disintegrating tablets [80mg & 160mg]", "externalId": "TK/ASD/AMD/2024/ACE/FP/RC/001/R1", "objectType": {"_id": {"$oid": "652411817ea5304f02443520"}, "externalId": "analyticalMethodDevelopmentReport", "displayName": "Analytical method development report", "version": 1}, "properties": [{"_id": {"$oid": "652411817ea5304f02443521"}, "externalId": "displayName", "displayName": "Report Name", "value": "Acetaminophen Orally Disintegrating tablets [80mg & 160mg]", "choices": []}, {"_id": {"$oid": "652411817ea5304f02443522"}, "externalId": "externalId", "displayName": "Report Number", "value": "TK/ASD/AMD/2024/ACE/FP/RC/001/R1", "choices": []}, {"_id": {"$oid": "652411d67ea5304f02443529"}, "externalId": "typeOfStudy", "displayName": "Type of Study", "value": "Related substance", "choices": []}, {"_id": {"$oid": "652413937ea5304f0244352a"}, "externalId": "reportDate", "displayName": "Report Date", "value": "1707849000", "choices": []}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec1"}, "externalId": "createdAt", "displayName": "Created At", "value": "1707910950"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec2"}, "externalId": "updatedAt", "displayName": "Updated At", "value": "1707910950"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec3"}, "externalId": "createdBy", "displayName": "Created By", "value": "382786184278302720"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec4"}, "externalId": "updatedBy", "displayName": "Updated By", "value": "382786184278302720"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec5"}, "externalId": "usageStatus", "displayName": "Usage Status", "value": "1"}], "relations": [{"_id": {"$oid": "652411c37ea5304f02443528"}, "externalId": "manufacturingProducts", "displayName": "Manufacturing Product", "targets": [{"_id": {"$oid": "6577e8494d4c4c4ae97b534b"}, "type": "OBJECTS", "collection": "manufacturingProducts", "externalId": "Paracetamol ODT", "displayName": "Paracetamol ODT"}], "objectTypeId": "6532d1fce5f40873f4aaebf6", "flags": 0}], "modifiedAt": 1707910950, "createdAt": 1707910950, "createdBy": {"_id": "382786184278302720", "employeeId": "3010", "firstName": "Prashantha", "lastName": "K"}, "modifiedBy": {"_id": "382786184278302720", "employeeId": "3010", "firstName": "Prashantha", "lastName": "K"}, "usageStatus": 1, "facilityId": "1693389002", "shortCode": "xLK0ZekRmU", "searchable": {"652411817ea5304f02443521": "Acetaminophen Orally Disintegrating tablets [80mg & 160mg]", "652411817ea5304f02443522": "TK/ASD/AMD/2024/ACE/FP/RC/001/R1", "652411c37ea5304f02443528": "6577e8494d4c4c4ae97b534b", "655ef3bb3484eb5056a36ec4": 382786184278302720, "655ef3bb3484eb5056a36ec5": 1, "652413937ea5304f0244352a": 1707849000, "652411d67ea5304f02443529": "Related substance", "655ef3bb3484eb5056a36ec1": 1707910950, "655ef3bb3484eb5056a36ec2": 1707910950, "655ef3bb3484eb5056a36ec3": 382786184278302720}, "_class": "com.leucine.streem.collections.EntityObject"}
Document 9 - ID: 65cf4c5260e5686f91fc6eff 
{"_id": {"$oid": "65cf4c5260e5686f91fc6eff"}, "objectTypeId": {"$oid": "652411817ea5304f02443520"}, "version": 1, "collection": "analyticalMethodDevelopmentReport", "displayName": "Water Content by KF Titration for Cetirizine Hydrochloride Orally Disintegrating Tablets 10 mg", "externalId": "TK/ASD/AMD/2024/CET/FP/WC/001/R0", "objectType": {"_id": {"$oid": "652411817ea5304f02443520"}, "externalId": "analyticalMethodDevelopmentReport", "displayName": "Analytical method development report", "version": 1}, "properties": [{"_id": {"$oid": "652411817ea5304f02443521"}, "externalId": "displayName", "displayName": "Report Name", "value": "Water Content by KF Titration for Cetirizine Hydrochloride Orally Disintegrating Tablets 10 mg", "choices": []}, {"_id": {"$oid": "652411817ea5304f02443522"}, "externalId": "externalId", "displayName": "Report Number", "value": "TK/ASD/AMD/2024/CET/FP/WC/001/R0", "choices": []}, {"_id": {"$oid": "652411d67ea5304f02443529"}, "externalId": "typeOfStudy", "displayName": "Type of Study", "value": "Water Content by KF Titration", "choices": []}, {"_id": {"$oid": "652413937ea5304f0244352a"}, "externalId": "reportDate", "displayName": "Report Date", "value": "1708021800", "choices": []}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec1"}, "externalId": "createdAt", "displayName": "Created At", "value": "1708084306"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec2"}, "externalId": "updatedAt", "displayName": "Updated At", "value": "1708084306"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec3"}, "externalId": "createdBy", "displayName": "Created By", "value": "400503640670298112"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec4"}, "externalId": "updatedBy", "displayName": "Updated By", "value": "400503640670298112"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec5"}, "externalId": "usageStatus", "displayName": "Usage Status", "value": "1"}], "relations": [{"_id": {"$oid": "652411c37ea5304f02443528"}, "externalId": "manufacturingProducts", "displayName": "Manufacturing Product", "targets": [{"_id": {"$oid": "6576dfd34d4c4c4ae97b50ac"}, "type": "OBJECTS", "collection": "manufacturingProducts", "externalId": "1700000784", "displayName": "Cetirizine HCl ODT 10 mg"}], "objectTypeId": "6532d1fce5f40873f4aaebf6", "flags": 0}], "modifiedAt": 1708084306, "createdAt": 1708084306, "createdBy": {"_id": "400503640670298112", "employeeId": "3011", "firstName": "Subrahmanya", "lastName": "B"}, "modifiedBy": {"_id": "400503640670298112", "employeeId": "3011", "firstName": "Subrahmanya", "lastName": "B"}, "usageStatus": 1, "facilityId": "1693389002", "shortCode": "xP4u98THSo", "searchable": {"652411817ea5304f02443521": "Water Content by KF Titration for Cetirizine Hydrochloride Orally Disintegrating Tablets 10 mg", "652411817ea5304f02443522": "TK/ASD/AMD/2024/CET/FP/WC/001/R0", "652411c37ea5304f02443528": "6576dfd34d4c4c4ae97b50ac", "655ef3bb3484eb5056a36ec4": 400503640670298112, "655ef3bb3484eb5056a36ec5": 1, "652413937ea5304f0244352a": 1708021800, "652411d67ea5304f02443529": "Water Content by KF Titration", "655ef3bb3484eb5056a36ec1": 1708084306, "655ef3bb3484eb5056a36ec2": 1708084306, "655ef3bb3484eb5056a36ec3": 400503640670298112}, "_class": "com.leucine.streem.collections.EntityObject"}
Document 10 - ID: 65d436f960e5686f91fc82cb 
{"_id": {"$oid": "65d436f960e5686f91fc82cb"}, "objectTypeId": {"$oid": "652411817ea5304f02443520"}, "version": 1, "collection": "analyticalMethodDevelopmentReport", "displayName": "Container Closure Integrity Test by UV for Sugammadex Injection 200mg/2mL & 500mg/5mL (100mg/mL)", "externalId": "TK/ASD/AMD/2024/SUG/FP/CC/001/R0", "objectType": {"_id": {"$oid": "652411817ea5304f02443520"}, "externalId": "analyticalMethodDevelopmentReport", "displayName": "Analytical method development report", "version": 1}, "properties": [{"_id": {"$oid": "652411817ea5304f02443521"}, "externalId": "displayName", "displayName": "Report Name", "value": "Container Closure Integrity Test by UV for Sugammadex Injection 200mg/2mL & 500mg/5mL (100mg/mL)", "choices": []}, {"_id": {"$oid": "652411817ea5304f02443522"}, "externalId": "externalId", "displayName": "Report Number", "value": "TK/ASD/AMD/2024/SUG/FP/CC/001/R0", "choices": []}, {"_id": {"$oid": "652411d67ea5304f02443529"}, "externalId": "typeOfStudy", "displayName": "Type of Study", "value": "Container Closure Integrity Test by UV", "choices": []}, {"_id": {"$oid": "652413937ea5304f0244352a"}, "externalId": "reportDate", "displayName": "Report Date", "value": "1708367400", "choices": []}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec1"}, "externalId": "createdAt", "displayName": "Created At", "value": "1708406521"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec2"}, "externalId": "updatedAt", "displayName": "Updated At", "value": "1708406521"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec3"}, "externalId": "createdBy", "displayName": "Created By", "value": "400503640670298112"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec4"}, "externalId": "updatedBy", "displayName": "Updated By", "value": "400503640670298112"}, {"_id": {"$oid": "655ef3bb3484eb5056a36ec5"}, "externalId": "usageStatus", "displayName": "Usage Status", "value": "1"}], "relations": [{"_id": {"$oid": "652411c37ea5304f02443528"}, "externalId": "manufacturingProducts", "displayName": "Manufacturing Product", "targets": [{"_id": {"$oid": "657fd28b4d4c4c4ae97b7556"}, "type": "OBJECTS", "collection": "manufacturingProducts", "externalId": "Sugammadex Injection", "displayName": "Sugammadex Injection"}], "objectTypeId": "6532d1fce5f40873f4aaebf6", "flags": 0}], "modifiedAt": 1708406521, "createdAt": 1708406521, "createdBy": {"_id": "400503640670298112", "employeeId": "3011", "firstName": "Subrahmanya", "lastName": "B"}, "modifiedBy": {"_id": "400503640670298112", "employeeId": "3011", "firstName": "Subrahmanya", "lastName": "B"}, "usageStatus": 1, "facilityId": "1693389002", "shortCode": "xVgfsdFIDm", "searchable": {"652411817ea5304f02443521": "Container Closure Integrity Test by UV for Sugammadex Injection 200mg/2mL & 500mg/5mL (100mg/mL)", "652411817ea5304f02443522": "TK/ASD/AMD/2024/SUG/FP/CC/001/R0", "652411c37ea5304f02443528": "657fd28b4d4c4c4ae97b7556", "655ef3bb3484eb5056a36ec4": 400503640670298112, "655ef3bb3484eb5056a36ec5": 1, "652413937ea5304f0244352a": 1708367400, "652411d67ea5304f02443529": "Container Closure Integrity Test by UV", "655ef3bb3484eb5056a36ec1": 1708406521, "655ef3bb3484eb5056a36ec2": 1708406521, "655ef3bb3484eb5056a36ec3": 400503640670298112}, "_class": "com.leucine.streem.collections.EntityObject"}